PET examinations utilizing PSMA ligands labeled with 68Ga or 18F, both highly effective nuclear imaging tracers, offer the capability to analyze the distribution of cancer cells in the body, particularly in prostate cancer. This evidence concerns the gene FOLH1 and Familial prostate cancer.